Harmony Biosciences

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$186,038
$172,814
$154,615
$168,412
Gross Profit
143,260
134,709
121,170
125,260
EBITDA
72,486
27,408
58,157
61,244
EBIT
66,518
21,356
52,033
55,119
Net Income
46,093
11,591
38,334
26,607
Net Change In Cash
186,038
172,814
154,615
168,412
Free Cash Flow
70,498
41,985
31,136
76,558
Cash
387,367
317,296
332,981
311,660
Basic Shares
58,103
57,541
57,597
58,853

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$582,022
$437,855
$305,440
$159,742
Gross Profit
460,786
354,374
249,922
132,004
EBITDA
231,278
120,355
87,544
13,915
EBIT
206,919
96,970
68,704
3,678
Net Income
128,853
181,468
34,597
-51,856
Net Change In Cash
582,022
437,855
305,440
159,742
Cost of Revenue
9,475
5,678
204,174
Free Cash Flow
219,075
104,294
-1,741
-4,987
Cash
311,660
243,784
234,309
228,631
Basic Shares
60,372
61,097
59,205
56,890

Earnings Calls

Quarter EPS
2024-09-30
$0.79
2024-06-30
$0.20
2024-03-31
$0.67
2023-12-31
$0.45